HIF1A and non-small cell lung carcinoma: Li et al. recognized that TGF-β-induced HIF-1α activation was mTOR dependent in MDSCs in non-small cell lung cancer (NSCLC) patients and was critical for CD39/CD73 induction under normoxic conditions.